Gwenn Hansen Nurix Therapeutics, Inc. (NRIX) insider trading activity
Gwenn Hansen is Chief Scientific Officer of Nurix Therapeutics, Inc.. Currently has a direct ownership of 61,516 shares of NRIX, which is worth approximately $768,950. The most recent transaction as insider was on Apr 01, 2021, when has been sold 400 shares (Common Stock) at a price of $31.55 per share, resulting in proceeds of $12,620. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
61.5K
9.97%
3M change
55.34%
12M change
Total Value Held
$768,950
Gwenn Hansen Transaction History
GH
Gwenn Hansen
Chief Scientific Officer
San Francisco, CA